Table 1 Age, histologic and intrinsic subtype of ESR1-mutated breast cancer with bone metastases

From: Estrogen receptor (ESR1) mutation in bone metastases from breast cancer

 

All patients

ESR1 mutated

Age (median, range, y=years)

69y, 27y–89y

73y, 55y–82y

BC, all types (%)

231 (100)

27 (100)

BC, no special type (%)

118 (51.1)

13 (48.2)

BC, lobular (%)

113 (48.9)

14 (51.8)

ER positive (%)

194 (84)

27 (100)

PR positive (%)

107 (46.3)

21 (77.8)

HER2 positive (%)

10 (4.3)

1 (3.7)

Triple negative (%)

33 (14.3)

0 (0)